BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient





 Company News
FDA Approves The Medicines Company (MDCO)'s Acute Skin Infection Drug Orbactiv 8/6/2014 5:30:57 PM
The Medicines Company (MDCO) To Host Infectious Disease Care Investor And Analyst Meeting On September 24, 2014 8/4/2014 10:07:50 AM
The Medicines Company (MDCO) Reports Second Quarter And First Half 2014 Results 7/23/2014 1:12:19 PM
The Medicines Company (MDCO) To Announce Second Quarter And First Half 2014 Financial Results On Wednesday, July 23, 2014 7/9/2014 10:58:02 AM
Controversial Trial Discovers No Benefit For Expensive The Medicines Company (MDCO) Drug 7/8/2014 6:30:00 AM
The Medicines Company (MDCO) Receives Market Authorization Renewal For Angiox® (Bivalirudin) From The European Medicines Agency And The European Commission 7/7/2014 10:13:38 AM
The Medicines Company (MDCO) Release: ORBACTIV™ (Oritavancin) Phase 3 Trial Results Published In The New England Journal of Medicine 6/5/2014 9:18:26 AM
The Medicines Company (MDCO) To Participate In Goldman, Sachs & Co. 35th Annual Global Healthcare Conference 6/5/2014 7:39:03 AM
The Medicines Company (MDCO) Release: Data On Angiox (Bivalirudin Injection) In Heart Attack Patients Presented At Europcr And Published In European Heart Journal 5/22/2014 10:20:09 AM
The Medicines Company (MDCO) Release: Data On Angiox (Bivalirudin Injection) In Heart Attack Patients Presented At EuroPCR And Published In European Heart Journal 5/22/2014 7:41:06 AM
12345678910...